text:
Indaba Music Licensing - Indaba Music
Indaba Music Licensing
We're looking to hand-pick the best music from the Indaba community to help our members make money from commercial placements.
NOTICE: This page will be closing soon.
Indaba is restructuring the way we handle our licensing catalogue over the coming month to better serve our members and our clients needs. As a part of this process we will stop accepting submissions to this Opportunity on Tuesday, Jan 21. We will be accepting new material into the Indaba Licensing Catalog through new contests and opportunities for our members. Check out the currently running Hip Hop Instrumentals contest, and watch for more coming in the near future. We love our members, and we love the music!
Thank you,
The Indaba Music Team
Over the last few years we've noticed one consistent fact: Indaba members make amazing music. Building on the success of the Artist Series, our new licensing service puts your music in front of music supervisors, record labels, publishers and more. We're excited to help you make money and get heard!
Submit high-quality recordings in any genre as long as you own or control all the rights. Indaba will review all submissions and will hand-pick recordings to include in our Licensing Catalog. See submission requirements below for more information.
Get Heard by Industry Professionals. We will shop your music to partners like music supervisors, publishers, record labels, and the biggest digital licensing businesses.
Make Money from Song Placements. We're in this together - you make music and we'll bring in opportunities. All income generated is split 50/50 between you and Indaba.
Feedback from Musicians. Collect feedback from other Indaba members and Indaba staff. We promise to listen to every song you submit.
- Keep 100% of your rights (composition and masters). It's that simple.
- Non-Exclusive. You to have complete flexibility and the ability to opt-out of the service.
Submission Requirements
- Submit your original songs in any genre to be considered for placement.
- Fill out meta-data for each song and agree to the licensing terms.
- Submit a WAV or AIFF audio file. MP3 files will not be accepted.
- Your files should be "broadcast-ready" (ie. fully-mixed and ready to go).
Does Your Song Include Vocals?
We strongly suggest that songs submitted with vocals also be submitted as an instrumental version. This greatly increases the likelihood of being selected for licensing.
For more information please read the FAQ.
Licensed Tracks
Check the status of your files on your licensing page.
Winners Announced:
What Else?
Opportunity Terms
ELIGIBILITY: This music licensing opportunity (�Licensing Opportunity�) is operated and hosted by Indaba Media, LLC (�Indaba�) on the Indaba Music Website, located at www.indabamusic.com (�Website�). This Licensing Opportunity is open to individuals who are 13 years of age or older at the time of entry and who are not presently signed to any record label or publisher under any exclusive agreements and/or other contractual arrangements which prohibit or might prohibit them from participating in any element of the Opportunity. VOID WHERE PROHIBITED BY LAW OR OTHERWISE.
ENTRY REQUIREMENTS. In order to enter this Licensing Opportunity entrants must register for a membership account with the Website (�Members�).
Follow the online instructions at http://www.indabamusic.com/account/signup to register. Valid Opportunity Members will submit recordings to the Opportunity (�Submissions�) for review and selection by Indaba, in its sole discretion. See the specific guideline for Submissions in the TO ENTER section below.
By entering a Submission in this Licensing Opportunity, Members hereby warrant and represent that the Submission conforms to the Opportunity Submission Requirements set forth herein (�Submission Requirements�). All Submissions must be in the following file formats: AIFF or WAV; and Submissions must meet the following Submission Requirements, and failure to abide by the Submission Requirements is grounds for disqualification in Indaba�s sole discretion:
Submissions must not contain material which is (or promoting activities which are) harmful, threatening, abusive, disparaging, harassing, vulgar, obscene, hateful, pornographic, or libelous or which has other inappropriate content, or is otherwise objectionable as determined by Indaba in its sole discretion;
Submissions shall not defame, misrepresent or contain disparaging remarks about any persons, products or companies;
Submissions shall not contain materials which are not created entirely by the Member or which are owned by others (other than audio to which the Member owns a license to use commercially, such as a purchased sample pack); and
Submissions shall not be in violation of any law.
BY ENTERING A SUBMISSION, MEMBERS ACKNOWLEDGE THAT INDABA RESERVES THE RIGHT TO, AND MAY OR MAY NOT, CHOOSE TO USE SUCH SUBMISSION, IN INDABA�S SOLE DISCRETION. By submitting a Submission, Members warrant and represent that: (a) the Submission is Member�s original work; (b) the Submission has not been previously published, (c) the Submission does not infringe upon the copyrights, trademarks, rights of privacy, publicity or other intellectual property or other rights of any person or entity; (d) Member has obtained permission from any person whose name or voice is used in the Submission; and (e) exploitation, use, display or performance of the Submission via any form of media, will not infringe the rights of any third parties. Members shall indemnify and hold harmless Indaba from any claims contrary to or in violation of these warranties and representations.
By entering this Licensing Opportunity, each Member agrees: (i) that Indaba shall have no obligation (express or implied) to use any Submissions in any manner and Members shall not be entitled to any damages or other relief by reason of Indaba�s use or non-use of a Submissions; (ii) to be bound by these Official Rules; (iii) that Members may be contacted by Indaba by email regarding this Licensing Opportunity; (iv) to indemnify and hold Indaba harmless from any and all claims, demands, causes of action and judgments (including attorney�s fees, court costs and expert�s fees) arising out of or relating to any breach by Members of the terms and conditions of these Official Rules, including any representations and warranties made herein. By entering the Licensing Opportunity, each Member agrees to sign and deliver to Indaba such documents as Indaba may reasonably require to effectuate the rights and obligations granted in these Official Rules.
GENERAL TERMS: In the event that a Submission is selected by Indaba, the applicable Member will be notified by e-mail and each such Member will be required to complete and electronically sign the Music Catalog License Entry Form, including the Music License Agreement, located at
www.indabamusic.com/licensing_catalog_entries as a condition of such Member�s Submission being selected by Indaba. Such Music Catalog License Entry Form and Music License Agreement are hereby incorporated in and made a part of these Official Rules. In the event that any Submission selected by Indaba is created by a Member who is a minor at the time of such selection, in addition to the information required above, such minor Member shall be required to have his/her parent or guardian complete, sign and return a Parent/Guardian Consent. In the event of noncompliance by a Member with these Official Rules, or if the Music Catalog License Entry Form and Parent/Guardian Consent, if required, are not properly executed, then that Member�s Submission shall not be used by Indaba until such time as the above referenced documents are properly executed, in Indaba�s sole discretion. Indaba reserves to right to edit the Music Catalog License Entry Form, excluding the following sections: Song Title; Main Artist/Performer; Additional Performers; Publisher; Master Owners; Song Writers; Performing Rights Society; and Labels. By participating in this Licensing Opportunity, Members release Indaba from any and all claims, damages or liabilities arising from or relating to such Member�s participation in this Licensing Opportunity, and agree to resolve any dispute individually, without resort to any class action Each Member grants permission to Indaba and those acting under its authority to use his/her name, photograph, voice and/or likeness, for advertising and/or publicity purposes, as well as the Submission, in any and all media now known or hereinafter invented without territorial or time limitations and without compensation. If for any reason this Licensing Opportunity is not capable of running as planned, including infection by computer virus, bugs, tampering, unauthorized intervention, fraud, technical failures, or any other causes which corrupt or affect the administration, security, fairness, integrity or proper conduct of this Licensing Opportunity, Indaba reserves the right, in its sole discretion, to cancel, modify or terminate the Opportunity. This Licensing Opportunity is governed by the laws of the state of New York, U.S.A. By entering, Members consent to the jurisdiction and venue of the federal, state and local courts located in New York, New York, U.S.A. for the resolution of any disputes. Members also agree to comply with all federal and state copyright laws.
LIMITATIONS OF LIABILITY AND RELEASE: No liability or responsibility is assumed by Indaba resulting from Members� participation in or attempt to participate in this Licensing Opportunity or downloading any information in connection with participating in this Licensing Opportunity. No responsibility or liability is assumed by Indaba for technical problems or technical malfunction which may affect the operation of this Licensing Opportunity, including but not limited to any of the following occurrences: hardware or software errors; faulty computer, telephone, cable, satellite, network, electronic, wireless or Internet connectivity or other online communication problems; errors or limitations of any Internet service providers, servers, hosts or providers; garbled, jumbled or faulty data transmissions; failure of any e-mail transmissions to be sent to or received; lost, late, delayed or intercepted e-mail transmissions; inaccessibility of the Website, in whole or in part for any reason; traffic congestions on the Internet or the Website; unauthorized human or non-human intervention of the operation of this Licensing Opportunity, including without limitation, unauthorized tampering, hacking, theft, virus, bugs, worms; or destruction of any aspect of this Licensing Opportunity, or loss, miscount, misdirection, inaccessibility or unavailability of an account used in connection with this Licensing Opportunity. Indaba is not responsible for any typographical errors in these Official Rules, or any inaccurate or incorrect data contained on the Website. Use of the Website is at Member�s own risk. Indaba is not responsible for any personal injury or property damage or losses of any kind which may be sustained to Members� or any other person's computer equipment resulting from participation in this Licensing Opportunity, use of the Website or the download of any information from the Website. Indaba is not responsible for any attempt by a Member or other individual to deliberately damage or undermine the legitimate operation of this Licensing Opportunity, including but not limited to any fraudulent claims, which may be a violation of criminal and civil laws. Should such an attempt be made, Indaba reserves the right to seek remedies and damages from any such individual, to the fullest extent permitted by law, including criminal prosecution. Indaba�s failure to enforce any term of these Official Rules shall not constitute a waiver of that provision. Persons engaging in any of the foregoing activities may be disqualified in Indaba�s sole discretion.
TO ENTER: Submissions must be master recordings consisting entirely of original musical compositions created by the Member. The Submissions may be in the any music genre for consideration by Indaba.
Entrants will upload their Submissions to the following location: http://www.indabamusic.com/opportunities/indaba-music-licensing and may continue to upload Submissions on an on-going basis until the License Agreement between Indaba and the applicable Member, required pursuant to these Official Rules, is terminated
GRANT OF RIGHTS: The rights granted under this Licensing Opportunity are subject to the terms and conditions of the Licensing Agreement. Each Member shall own one hundred percent (100%) of the copyright to their Submission. By entering this Licensing Opportunity, each Member agrees, or shall irrevocably cause any of Member�s designees, licensees, assignees to agree: that if the Member is selected for inclusion in this Licensing Opportunity, Indaba has the perpetual, gratis right to use the Member�s Submission and Member�s name and likeness in any and all media, now known or hereafter devised, in connection with promotion, publicity, marketing and advertising for and by Indaba, and in connection with this Licensing Opportunity or other promotions by Indaba.
Indaba, in their sole discretion, will select Members� Submissions (�Selected Submissions�) to be included in Indaba�s music license catalog for general licensing and business purposes.
The Selected Submission will be selected on an ongoing basis during the course of this Licensing Opportunity.
Entrants acknowledge that Indaba shall have no obligations, financial or otherwise, to the Members, except for those explicitly set forth in these Official Rules and the License Agreement.
Members agree that Indaba has the sole right to decide all matters and disputes arising from this Licensing Opportunity and that all decisions of Indaba are final and binding.
INDABA: Indaba Media, LLC, 568 Broadway, 11th Floor, New York, NY 10012


text:
You can now filter search results with text. Example: "person: john" will search only person pages for "john".
Nintendo's struggled to make a memorable Yoshi game since Yoshi's Island, and this new 3DS platformer isn't going to change that.
You're never going to be bored in Hope's Peak Academy's wild world of murder, despair, and bears, but you might occasionally wonder why it's a game.
Titanfall's focus on player mobility and big-ass robots sets it apart from other competitive shooters and makes much of the game look like one big highlight reel.
Game » consists of 3 releases. First released on Mar 22, 2004
Abra is a psychic-type pokemon from the original Pokemon Red/Blue. With spoon-bending powers, he attacks using his mind.
Absol is a dark-type pokemon from Pokemon Ruby/Sapphire. From the shadows Absol strikes out at an unwary foe.
When a game inclüdes an accènt in its title.
Aerodactyl is a rock/flying-type pokemon first found in the original Pokemon Red/Blue. Aerodactyl is formed from old amber, blood from the creature trapped inside the amber allowing scientists to revive Aerodactyl to full health.
Third generation Rock-Steel type Pokemon which evolves from Aron and Lairon
A Johto native, Aipom is a small normal type pokemon that has resembles a small monkey and has a large hand on the end of it's tail.
An innate ability to control the behavior and direction of the air. This ability can also be used to create and control bursts of wind.
Alakazam is a psychic-type pokemon from the original Pokemon Red/Blue. As the evolution of Kadabra, Alakazam is the third in a line of powerful spoon-bending psychics.
A Pokemon which appears to be engulfed in a cloud.
In many games the player is given the power to harm and or kill creatures. Many games have been brought to spotlight by groups like the rather militant PETA.
This Bug/Rock type Pokemon can be found in Pokemon ruby and Sapphire.
A majestic and fierce fire pokemon, Arcanine is the evolved form of Growlithe.
Some games offer alternate modes or specific sections of the storyline that involve arena combat, gladiator style.
A Pokémon first found in Johto. It evolves from Spinarak.
Armaldo is an ancient Pokémon that must be revived from a fossil. It has the ability to blow players' minds upon realisation that the red spots on its head aren't actually its eyes.
A Pokemon first found in Hoenn. It evolves into Lairon.
Articuno is a ice/flying-type legendary pokemon. Using its great wings, Articuno blasts powerful Arctic-cold air toward its opponents.
Azumarill is a water-type pokemon first seen in Pokemon Gold/Silver. This pokémon evolves from Marill starting at level 18, and is the second evolution of Azurill.
Azurill is a normal-type pokemon from Pokemon Ruby/Sapphire. Azurill is a baby pokemon, the pre-evolution of Marill.
Bagon is a dragon-type pokemon first seen in Pokemon Ruby/Sapphire. Bagon may look small but his bite is nothing to be laughed at.
This Ground/Psychic Pokemon is found in Pokemon Ruby and Sapphire for the Gameboy Advance.
Banette is a ghost-type pokemon first found in Pokemon Ruby/Sapphire. Banette is the discarded toy of children and it can often be found wandering in search of their owners who abandoned them.
This Water/Ground type Pokemon is found in Pokemon Ruby and Sapphire.
Bats are small flying mammals. They may frequent caves or haunted houses.
A mechanic used mainly in Japanese RPGs of both the action and turn-based variety.
Bayleef is a grass-type pokemon first found in Pokemon Gold/Silver. As an evolution to the grass-type starter Chikorita, Bayleef is stronger and more ferocious.
Beautifly is a Bug/Flying-type pokémon from Pokémon: Gold and Silver. Using its beauty to entrance its enemies, Beautifly attacks from above with a flurry of wings.
Bedrill is a Bug/Poison type Pokémon that evolves from Kakuna. They totally look like bees.
A Steel and Psychic-type Pokemon which first appears in Pokemon Ruby and Sapphire for the Game Boy Advance.
A small Grass pokemon. It it very thin and flexible.
This edit will also create new pages on Giant Bomb for:
Until you earn 1000 points all your submissions need to be vetted by other Giant Bomb users. This process takes no more than a few hours and we'll send you an email once approved.
Because you're new to wiki editing, we sent your submission off to our moderators to check it over. Most changes are approved within a few hours. We'll send an email when it is.
Once you've earned over points you'll be able to bypass this step and make live edits to our system. Until then, gain points by continuing to edit pages.
No changes were submitted, nothing was done! Please make changes to the wiki!
Thanks for continuing to improve the site. Some of your changes are now live. However, some of your changes were sent to moderation because you do not have enough points to make those live edits. You need points to live edit the changes you commited.
For the changes that went through, our robot math gave you points for this submission.
Thanks for continuing to improve the site. Your changes are now live. Our robot math gave you points for this submission.
Use your keyboard!
Log in to comment

subset: commoncrawl


text:
Before , I questioned on a favorite place in Japan .
However , do you know the special product of the place ?
The special product is sold as a souvenir .
Even if the souvenir is gotten , I am grad , and buying it is also happy .
And it is one of the purpose of the travel to buy the souvenir .
There are a lot of souvenirs in Japan .
They are foods , close , and so on .
If I am not Japanese , I buy Japanese style confection .
If you are not in your country , what do you buy ?


text:
Dean's Blog
Blog Editors
Kevin R. Johnson
UC Davis School of Law
Web Profile
Vikram Amar
UC Davis School of Law
Web Profile
Recent Posts
Visiting King Hall Alumni in the Central Valley
JJLP Symposium on Human Trafficking, Sexual Exploitation of Youth
King Hall Connections to the Sergio Garcia Case
Class of 2013 Bar Exam Pass Rate Places UC Davis among Best in the State
National Jurist Op-Ed on the Law Student Budget Advisory Committee at King Hall
BAAPALSA Conference 2014 at King Hall
A Meeting of the California Lawyer Magazine Editorial Advisory Board
Dr. Martin Luther King, Jr. Holiday 2014: Celebrating the King Hall Connection
A True King Hall Saturday: Carr Competition and Reunions
San Mateo County Bar Association Presentation on Accessibility to Education
Guest Blog Entry: Unity Bar Dinner 2013
State Bar Annual Meeting in San Jose
2013 Steve Boutin Invitational Golf Tournament
Special Screening of Immigration Documentary in Sacramento
Jose Antonio Vargas Speaks at King Hall
Annual BLSA Potluck with Professor Lewis
Professor Peter Lee Honored as Chancellor's Fellow
"Law and Race" Workshop at Stanford Law School
King Hall Alum Gets the Game Ball
UCDC Students Meet Justice Scalia
Admitted Students Weekend, Patiño Banquet, and Neumiller Competition
UC Davis Student-Athlete Career Night Panel
King Hall Weekend: Black Alumni Reunion and Dr. Ives Tournament
Christopher Gorman '14 Honored with Writing Award
NYTimes Op-Ed: Law School Is Worth the Money
Student Guest Blog Entry: California Law Revision Commission Externship
Appearance in Chilean Newspaper
The Law School's Valuable Relationship with Chile
King Hall Presence at Leadership Conference
Guest Entry: Humanitarian Aid Legal Organization Honors Custodial Staff
Unity Bar Dinner 2012 and Justice Moreno
Dowdalls, Suliman Win 2012 Carr Competition
GAAAP Law Symposium at King Hall
Shenandoah Screening at UC Davis School of Law
Guest Entry: BLSA Gathering by Professor Lewis
California Supreme Court Clinic Video
Professor Rose Cuison Villazor Joins ImmigrationProf Blog
King Hall to Host Talk and Documentary on Immigration
California Supreme Court at King Hall
Counting Down to the California Supreme Court Special Session
Honoring the Diversity Fellows
Mississippi Abortion Law and the Power of Federal District Court Judges
King Hall Outreach Program (KHOP) 2012
Boxing Analysis by Emilio Camacho '11
Hosting the China University of Political Science and Law (CUPL) Delegation
The Top 10 Things to Take Away From Last Week's Supreme Court Obamacare Ruling
UC Davis Welcomes New Athletic Director
U.S. Supreme Court Rules on Arizona Immigration Law
AALS 2012 Workshop for New Law Teachers
Public Law Center Annual Dinner
Justice Kathleen Butz '81 Leads Inn of Court
Tom Stallard '75 Re-elected to City Council
Boxer Robert "The Ghost" Guerrero at King Hall
Obamacare and the Misguided Criticism of "Liberal Law Professors" Who Defend It
King Hall Alum Launches School Board Campaign
Citizens United and Jeffrey Toobin's Account of it in The New Yorker
Admitted Students Reception in SF
Environmental Law Certificate Ceremony
Immigration and Poverty Conference
The U.S. Supreme Court's Low Favorability Rating
Inn of Court: First Amendment and the Occupy Movement
Luis Alejo '01 Proposes on Assembly Floor
King Hall Students at California Women Lawyers Annual Conference
A Prediction in Arizona v. United States
Jihan Kahssay '12 Wins 2012 Pritikin Prize
Celebrating a Great Year (2011-12)
PolicyMic Debate on Arizona Immigration Law
King Hall's International Reach
Guest Blog Entry: Inaugural APALSA Banquet
Female Justices Make History in Sacramento
Lucas Guttentag on Civil Rights and Immigrant Justice
Admitted Students Weekend 2012
Bill Smith Memorial Lecture 2012
Sneak Peek at King Hall's Lower Level Renovation
Guest Blog Entry: ABAS Celebration 2012
King Hall Students at Environmental Law Conference in Oregon
SCOTUSblog: Court rejects retroactive application of 1996 immigration law amendment
King Hall Students and Trayvon Martin Solidarity Gathering
Presenting on Immigration Law from Coast to Coast
King Hall Alum Runs for Oakland City Council
Honored to Receive the Romero Vive Award
Attending the Chief Justice's State of the Judiciary Address
Speaking at Chapman University
King Hall Student Lobbies in Washington, D.C.
Clement Kong '75 and Family Visit Named Classroom
UCDC Students Meet U.S. Supreme Court Justice Breyer
Naturalization Training at King Hall
Moot Court Event on "Obamacare"
Chief Justice Visits Class of 2014
Junior High Students/Future Lawyers Visit King Hall
Lectures and Symposia at King Hall
Human Rights & Humanities Week at UC Davis
2012 Distinguished Teaching Award and Scholarship Recognition Celebration
Baseball Attorney Scott Boras Visits UC Davis
Events this Monday: Dukakis, Boras
ABA Regional Client Counseling Competition
The Right Way to Accommodate Religious Objections to the Contraception Coverage Mandate
Revisiting Standing: Proposition 8 in the Ninth Circuit
New Video on King Hall Legal Clinics
Message from Trial Practice Honors Board
Angela Davis to Speak at UC Davis on Social Justice in the UC System
Megan Glanville Scholarship Fund
King Hall Hosts ABA Client Counseling Competition Next Weekend
Negotiations Team Announcement
Asylum & Refugee Law National Moot Court Competition
2012 Fenwick & West Symposium on Social Media: "Connect!"
Announcing the UC Human Rights Fellowship Competition for 2012
Law Student Learns Advocacy at NAGPS Conference
Professor Sunder on Cultural Sharing Amidst Global Inequalities
Visiting Alumni and Prospective Students in the Bay Area
Top 10 Blogs on Immigrants' Rights
Guest Post from Nicholas Starkman '13: A Complicated Deportation Case
Thoughts on Vartelas v. Holder on SCOTUSblog
Sara Granda '09 Gets Her Stolen Van Back
Alumnus Profiled in Whittier Student Paper
Preview of Vartelas v. Holder for SCOTUSblog
Welcome Back Message, Spring 2012
AALS Meeting Recap: Reception and Honors for Professor Aoki
Film Screening: Bringing King to China
Join King Hall's Reception in Washington, DC
Media Profiles Professor Emeritus Cruz Reynoso
Law Student's Thesis on Militarization of the U.S./Mexico Border
Top Ten Immigration Stories for 2011
Associate Dean Amar on Fisher v. Texas
Opinion Analysis of Judulang v. Holder for SCOTUSBlog
Memorial Service for Alumni Board President John Schick
Chief Judge Kozinski Lecture Video Now Online
King Hall APALSA Students Share Photos from Atlanta Conference
Sacramento Bee Op-ed: Let UC Davis Probes Take Their Course
Environmental Law Society Students Attend Conference in Yosemite
Professor Emeritus Reynoso and the Documentary "Why We Come"
"Why Poverty Research Matters"
U.S. News Rankings and Diversity
Angela Onwuachi-Willig Delivers Bodenheimer Lecture
Tribute to Presiding Justice Vance Raye
Immigration Law Clinic Naturalization Fair in Winters
Chief Judge Alex Kozinski Is the McClatchy Jurist in Residence at King Hall
Entertainment and Sports Law Society
Law Student and Boxing Expert Ryan Maquiñana '12
British Guitarist Loves King Hall
King Hall Students Present Accepted Papers at XVI Annual LatCrit Conference
Weekend Sports, King Hall Style
U.S. Attorney General Live Video Event at King Hall
CSIS Presents Forensic Performances
Celebrating the 2010-11 Academic Year
CSIS Symposium "Bayh-Dole at 30" and Professor Aoki
Great King Hall Events and the MLK Community Service Award
King Hall Student Attends ABA Antitrust Conference
Postcard from Florence, Arizona
Anniversary, Panel, and Admissions Weekend
Honoring Jack Ayer and Endowed Chair Donors
Business & Tax Law Mixer at Downey Brand
'Top Scholar' Emilio Camacho '11 Profiled in Hispanic Executive
La Raza Law Students Host César Chávez Week
Chancellor Katehi Highlights King Hall's Rise in Rankings
ABA/AALS Site Inspectors Meet King Hall Alums
King Hall Places 23rd in U.S. News Rankings
Angela Harris, Ashutosh Bhagwat, and Jack Chin Join King Hall!
Esmeralda Soria '11 Publishes Essay in Daily Journal's "New Lawyer"
Chief Justice Visits King Hall
King Hall 3L in Mexico City – Final Guest Blog
Governors' Global Climate Summit 3
King Hall 3L in Mexico City, Part 3
Law Students Present to Chicano Studies Class
King Hall 3L in Mexico City, Part 2
ImmigrationProf Reaches One Million Hits
Guest Blog on La Raza Lawyers Charitable Foundation
LSA President, Attorney, and "Football Wife"
King Hall Makes Cameo in TV Ad
A Full Menu of Lunchtime Events
Congrats to Two-time Scholarship Winner Aidin Castillo
KHOP Student Named Polanco Fellow
Immigration Law Clinic Holds Citizenship Workshop in Sacramento
Black Law Students Karaoke Night
Alum Scores Victory for Facebook Privacy
Dean Kulwin's Tips for Bar Study
Guest Blog Entry on L.A. Lunch
Latino Leader Roundtable Discussion on Arizona Immigration Law SB 1070
Alumni and Admitted Students Reception in San Francisco
Court Awards Trial Costs to Clinics
Professor Tanaka: Ten Gallon Donor
Read Wajahat Ali '07 on Salon.com
Latino Legislative Caucus Spirit Awards
King Hall Represented at API Policy Summit
Notes from the U.S./Mexico Border South of San Diego, California
Dean Johnson Is "The Boss" on Sirius Satellite Radio
Alumni and Admitted Students Reception in Los Angeles
Professor Holly Cooper Guest Blogs from Haiti
UC Davis Students Represent in Stockton
King Hall Student and Community Service
Experts Discuss "Immigration: Educational, Economic, and Political Perspectives"
Jeffrey Toobin and UC Davis School of Law at the Sacramento Speakers Series
California Aggie: Wajahat Ali '07 "Triumphs"
Week in Review: Rudi Bakhtiar, Judge Reinhardt, Professor Martha Nussbaum, and the Asian Century
King Hall Civil Rights Clinic in the L.A. Times
King Hall's Tom and Meg Stallard to Lead Picnic Day Parade
UC Davis Law Review Symposium: The Asian Century?
Professor Reynoso's Civil Rights Commission in the News
Professor Cruz Reynoso and Independent Civil Rights Commission to Investigate Gutierrez Shooting
10th Anniversary Celebration for the Family Protection and Legal Assistance Clinic
Alejo '01 Official Campaign Kickoff
SABA Picture Gallery in Sacramento Lawyer Magazine
Revisiting King Hall: Milestone Reunions 2009
King Hall Professor Endorses King Hall Alumnus
King Hall in San Francisco Attorney Magazine
Countdown to TESLaw at King Hall
A Guest Appearance in the Blogosphere
King Hall at UC Davis' Fall Convocation
Professor Lee: King Hall's Champion Baller
Movie Review: Brother Towns
Posted By Kevin R. Johnson, Aug 13, 2010
Bullfrog Films asked me to provide a review for its latest production, a film titled "Brother Towns/Pueblos Hermanos." Bullfrog is a leading provider of educational films and DVDs. Here's a description of the film from the Bullfrog website: "Brother Towns is a story of two towns linked by immigration, family, and work: Jacaltenango, a highland Maya town in Guatemala; and Jupiter, a coastal resort town where many Jacaltecos have settled in Florida.
Brother Towns chronicles a story of how and why people migrate across borders, how people make and remake their communities when they travel thousands of miles from home, and how people maintain families despite their travel. Because we are all immigrants, this is a universal human story, and a quintessential American one. All of us understand family.
Brother Towns is also a story of local and international controversy. News of undocumented immigrants is familiar in nearly every community across the U.S., and citizens must choose how they respond to this issue." I thought the film told a very insightful, very human story. To read my review, visit http://www.bullfrogfilms.com/catalog/brt.html .


text:
change text size
You are here:
The only fully talking big button and large screen telephone that announces every button press and menu selection in a clear female voice. Reassuring you that the number you dialled is correct and the function you want is selected. A truly unique telephone that is accessible to all!
Product instructions (Word, 200.00KB)
£99.98 inc VAT
£83.32 ex VAT
Blind and partially sighted customers will not pay VAT
Back to Corded telephones
0 items
Call our Helpline on 0303 123 9999 or fill out the form below and we'll call you back.
We are open Monday to Friday 8:45am to 5:30pm. Thank you for your continued support whilst we find a solution.
Fields marked with an asterisk (*) must be filled in.
First name: *
Last name: *
Phone number: *
Email: *
House number:
Account number (if known):
What do you want to buy or ask?


text:
Big ideas start here
CSIRO aims to establish and build relationships with members of the community. We welcome people of all ages to come and explore our facilities, holiday programs and public events.
Phone: 1300 363 400
Email: email@example.com
CSIRO, the Commonwealth Scientific and Industrial Research Organisation, is Australia's national science agency and one of the largest and most diverse research agencies in the world.
Large-scale, long-term, multidisciplinary science to address Australia's major national challenges and opportunities.
CSIRO expertise is organised into 11 research areas
CSIRO manages national facilities and collections that are opened to researchers around Australia and overseas.
Time: 2:37 | View the transcript
Communication Manager
Preventative Health Flagship
Phone: +61 8 8303 8888
Alt Phone: +61 4 0775 1330
Email: firstname.lastname@example.com
Level 3, Elizabeth House231 North Terrace
Adelaide SA 5000
PO Box 10041


text:
Emma Watson Graces T Magazine's Fall Issue in Evocative Style
The Graduate – Effortlessly blending youthful charm with elegance, Emma Watson talks to T, The New York Times Style Magazine about returning to film after her Oxford and Brown University hiatus. Emma channels retro it-girls like Edie Sedgwick with a collegiate twist in autumn looks styled by Anastasia Barbieri. The cover story, lensed by Alasdair McLellan, finds the new face of Lancôme and Perks of Being a Wallflower star wearing selects from the likes of Bottega Veneta, Ralph Lauren, Comme des Garçons, Isabel Marant, and Burberry Prorsum. / Hair by Luke Hersheson @ Julian Watson Agency, Makeup by Val Garland @ Streeters
Read the article on NYTimes.com


text:
Follow UAB-CORD on Twitter for News and Updates about our programs.
CORD offers grade K-12 students and teachers from all areas in-depth, hands-on, inquiry-based science experiences both during the school year and in our more intense summer programs. Students experience these programs at their Birmingham area schools, at CORD's GENEius and LabWorks classrooms at the McWane Science Center and in CORD's laboratory classrooms at UAB.


text:
Amac Keylogger Standard is an undetectable keylogger for Mac OS X that secretly records typed keystrokes, visited websites in Safari/Firefox/Chrome, chat conversations from Skype/AIM/iChat/Adium/MSN, desktop screenshots, and IP addresses. It automatically sends logs to your email or FTP space at preset intervals. Users can easily enable Amac Keylogger Standard to monitor activities from all user accounts on a Mac.
A wireframes, mockup, and prototype tool for desktop, Web, and mobile applications.


text:
About Us
Charitable Solicitation Disclosure
The Nature Conservancy publishes detailed financial summary information as a part of its annual reports, financial reports, and IRS 990 forms.
Financial information about The Nature Conservancy may be obtained by contacting us at 4245 North Fairfax Drive, Suite 100, Arlington, VA 22203; (800) 628-6860, or as stated below:
Colorado | Colorado residents may obtain copies of registration and financial documents from the office of the Secretary of state by calling 303-894-2200 ext. 6487 or by visiting the web. | |
Florida | A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE, 1-800-435-7352 WITHIN THE STATE. REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE. CH - 694 | |
Georgia | The following information will be sent upon request: (A) A full and fair description of the charitable program for which the solicitation campaign is being carried out and, if different, a full and fair description of the programs and activities of the charitable organization on whose behalf the solicitation is being carried out; (B) A financial statement or summary which shall be consistent with the financial statement required to be filed with the Secretary of State pursuant to Code Section 43-17-5 | |
Maryland | Documents and information submitted under the Maryland Solicitations Act are also available, for the cost of postage and copies from the Secretary of State, State House, Annapolis, MD 21401. | |
Michigan | MICS-6446 | |
Mississippi | The official registration and financial information of The Nature Conservancy may be obtained from the Mississippi Secretary of State's office by calling 1-888-236-6167. Registration by the Secretary of State does not imply endorsement. | |
New Jersey | INFORMATION FILED WITH THE ATTORNEY GENERAL CONCERNING THIS CHARITABLE SOLICITATION AND THE PERCENTAGE OF CONTRIBUTIONS RECEIVED BY THE CHARITY DURING THE LAST REPORTING PERIOD THAT WERE DEDICATED TO THE CHARITABLE PURPOSE MAY BE OBTAINED FROM THE ATTORNEY GENERAL OF THE STATE OF NEW JERSEY BY CALLING 973-504-6215 AND IS AVAILABLE ON THE INTERNET AT www.njconsumeraffairs.gov/ocp.htm#charity. REGISTRATION WITH THE ATTORNEY GENERAL DOES NOT IMPLY ENDORSEMENT. | |
New York | Upon request, a copy of the latest annual report can be obtained from the organization or from the Office of the Attorney General by writing to the Charities Bureau at 120 Broadway, New York, NY 10271. | |
North Carolina | Financial information about this organization and a copy of its license are available from the State Solicitation Licensing Branch at 1-888-830-4989. The license is not an endorsement by the State. | |
Pennsylvania | The official registration and financial information of The Nature Conservancy may be obtained from the Pennsylvania Department of State by calling toll-free, within Pennsylvania, 1-800-732-0999. Registration does not imply endorsement. | |
Virginia | Financial statements are available from State Division of Consumer Affairs, Department of Agricultural and Consumer Services, PO Box 1163, Richmond, VA 23218. | |
Washington | The notice of solicitation as required by the Charitable Solicitation Act is on file at Charities Division, Office of the Secretary of State, State of Washington, Olympia, WA 98504-0422, 1-800-332-4483. A potential donor can obtain additional financial disclosure information at a published number in the office of the secretary. | |
West Virginia | Residents may obtain a summary of the registration and financial documents from: Secretary of State, State Capitol, Charleston, WV 25305. Registration with any of these states does not imply endorsement. |
We respect your privacy and preferences. If you have questions about your membership or would like to modify your mailing preferences, please call our Member Care team at (800) 628-6860, write to us at 4245 N. Fairfax Dr. Suite 100, Arlington, VA 22203 or visit Member Care.


text:
Please enter your travel dates.
Standard Room - All Inclusive
Family-friendly all-inclusive resort in Marina Vallarta
When you stay at Vamar Vallarta Marina & Beach Resort in Puerto Vallarta, you'll be on the beach and minutes from El Faro Lighthouse and Marina Vallarta.
This all-inclusive resort is within close proximity of Marina Golf Club and International Convention Center.
Make yourself at home in one of the 253 air-conditioned rooms featuring plasma televisions. Relax and take in pool and courtyard views from the privacy of your room. Complimentary wireless Internet access keeps you connected, and cable programming is available for your entertainment. Private bathrooms have rainfall showerheads and complimentary toiletries.
Take in the views from a garden and make use of amenities such as complimentary wireless Internet access and babysitting/childcare (surcharge). Additional amenities include gift shops/newsstands, wedding services, and a television in the lobby.
This resort offers both all-inclusive and room-only rates. Meals and beverages at onsite dining establishments are included in all-inclusive rates. Charges may be applied for dining at some restaurants, special dinners and dishes, some beverages, and other amenities.
Satisfy your appetite at one of the resort's 3 restaurants. When you are in need of a refreshing drink, visit a poolside bar or one of 2 bars/lounges, or 2 swim-up bars. A complimentary buffet breakfast is served daily.
Featured amenities include an Internet point, a 24-hour front desk, and multilingual staff. Event facilities at this resort consist of banquet facilities, exhibit space, and a meeting/conference room. Parking is conveniently located nearby.
Hotel Amenities
- All-Inclusive Details
Guests can book rooms at Vamar Vallarta Marina & Beach Resort for a rate that is either for the room only or for all-inclusive. All-inclusive rates are higher because they include onsite food and beverages in the room rate (some restrictions may apply).
Gratuities and taxes
Gratuities and taxes are included.
Food and beverages
- All buffet and à la carte meals, snacks, and beverages included
Activities and facilities/equipment
All non-motorized water sports are included.
Water activities
- Kayaking
- Surfing/boogie boarding
Land activities
- Bicycling
- Volleyball
- Aerobics
- Dancing
- Water aerobics
Kids' club
- Supervised activities for children between 4 and 12 years old
- Onsite entertainment and activities
- Onsite live performances
Not included
- Airport transfers
- Childcare
- Laundry/dry cleaning services
- Motorized water sports
- Scuba-diving certification
- Scuba-diving lessons
- Spa/beauty facilities and services
- Activities and services offered by independent operators
- Offsite tours
- General
This hotel is located in Marina Vallarta and offers direct access to the beach and the marina boardwalk with its numerous restaurants and boutiques. A golf course is just a stone's throw away. There are four swimming pools (including one kids' pool) and an impressive atrium lobby.
Guests can take part in scheduled activities from early morning until late afternoon. A dynamic activities team organizes karaoke, aqua aerobics, table games, and volleyball tournaments. Dance lessons are offered in a variety of styles. The hotel's Mini Club provides a supervised activities program and playground for children ages 4–12. Babysitting services are available for a surcharge. Complimentary wireless Internet access is available in all areas of the hotel.
- Marina on site
- Babysitting or childcare (surcharge)
- Supervised childcare/activities (free)
- Multilingual staff
- 24-hour front desk
- Safe-deposit box at front desk
- Tour assistance
- Children's club
- Banquet facilities
- Elevator/lift
- Number of bars/lounges 2
- Number of swim-up bars - 2
- Exhibit space
- Internet point
- Total number of rooms - 253
- Number of floors - 9
- One meeting/conference room
- Parking nearby
- Poolside bar
- Luggage storage
- Free covered parking
- Free outdoor parking
- Number of restaurants - 3
- Smoke-free property
- Television in lobby
- Free breakfast
- Gift shops or newsstand
- Free Wi-Fi
- Number of outdoor pools - 3
- Beach/pool umbrellas
- Garden
- Porter/bellhop
- Security guard
- Swimming pool - children's
- Wedding services
- Internet
Available in all rooms: Free Wi-Fi
Available in some public areas: Free Wi-Fi
- Parking
Free covered parking, Free outdoor parking, Parking nearby
- Room Amenities
- Plasma TV
- Air conditioning
- Phone
- Wake-up calls
- Daily housekeeping
- Hair dryer (on request)
- In-room safe
- Iron/ironing board (on request)
- Rollaway/extra beds available
- Ceiling fan
- Free Wi-Fi
- Turndown service
- Private bathroom
- Complimentary toiletries
- Rainfall showerhead
- Electronic/magnetic keys
- Cable TV service
- Courtyard view
- Pool view
- Dining
A complimentary breakfast is served daily between 7-11 AM.
Lobby Bar - Open from early evening to 1 AM.
Bita Pool Bar - Open from late morning to 6 PM.
La Joya Pool Bar - Next to the sea and surrounded by beautiful gardens.
Caracol Pool Bar - Open from late morning early evening.
La Villa - seafood restaurant open for lunch.
Café Marina - Buffet-style restaurant located in front of the main canal of the marina. Guests can watch the boats go by while enjoying breakfast, lunch, and dinner.
Caracol - Restaurant with a bar, open every afternoon daily.
Restaurant Magallanes - International and Italian fine cuisine, served à la carte for lunch and dinner. Restaurant has a bar.
- Recreation
Vamar Vallarta Marina & Beach Resort offers direct access to the beach and four swimming pools, including one kids' pool. Guests have the use of kayaks and boogie boards, and can participate in aquatic volleyball, polo, and aerobics. Windsurfing, parasailing, and fishing are available nearby (surcharge).
Complimentary volleyball and aerobics are offered on site. Guests can enjoy a preferred rate on green fees at the El Tigre Club de Golf in Paradise Village.
The recreational activities listed below are available either on site or near this Puerto Vallarta, Mexico hotel; fees may apply.
- Golfing nearby
- Snorkeling nearby
- Boating nearby
- Windsurfing nearby
- Sailing nearby
- Horse riding/rental nearby
- Parasailing nearby
- Fishing nearby
- Whale-watching nearby
- Motor boating nearby
- Running track/path nearby
- Aerobics on site
- Kayaking on site
- Swimming on site
- Volleyball on site
- Ecotours nearby
- Accessibility
To make requests for specific accessibility needs, complete the "Special or Accessibility Requests" section of "Trip Preferences" when you book your hotel.
- Accessible path of travel
- Accessible parking
Policies & Fees
- Check-in
Check-in time starts at 3 PM
- Check-out
Check-out time is noon
- Payment types
Accepted at this hotel: American Express, MasterCard, Visa
- Pets
Pets not allowed
- General
Extra-person charges may apply and vary depending on hotel policy.
Government-issued photo identification and a credit card or cash deposit are required at check-in for incidental charges.
Special requests are subject to availability upon check-in and may incur additional charges. Special requests cannot be guaranteed.


text:
Where: Don Pablos - 2745 Fairfield Commons Blvd, Beavercreek, OH 45431
Student Activities site banner
Take flight and soar with exciting opportunities for student involvement at Wright State. Going to Wright State is about making the most of your life as a student. As you get involved, you'll not only have a lot of fun, you'll also develop your leadership abilities, raise your consciousness, and acquire skills you'll use after college.
Getting involved is easy! Just go to the listing of organizations and contact the President of the organization(s) that match your interests.
Stop by our new office on the lower level of the Student Union or give us a call at (937) 775-5570 if you have questions or would like to get involved on campus!
Richard A. Danals, Ph.D.
Theta Phiesta
Where: Don Pablos - 2745 Fairfield Commons Blvd, Beavercreek, OH 45431
Want to Become a President's Ambassador?
Student Activities Photos
Upcoming Events
Upcoming Events
Make a Gift
Make a Gift
With your gift, Student Activities can provide students even more opportunities to develop their leadership skills, increase their involvement with the university, and provide them meaningful experiences to prepare them for life after college.
Additional Links
Additional Links
The Gay, Lesbian, Transgender, Questioning and Ally (GLBTQA) Resource Room website is designed to collectively bring together information about GLBTQA programs and services in one convenient location for Wright State University students, faculty and staff.


text:
Dr. Hanson has just completed his interventional radiology fellowship at the Hospital of the University of Pennsylvania in Philadelphia, PA. He received his MD from the University of Iowa in Iowa City in 1995 and completed his diagnostic radiology residency at the University of Utah in Salt Lake City in 2000. Dr. Hanson will be joining Medical X-Ray Consultants in Eau Claire, WI, in July 2001.
Dr. Michael Soulen is an Associate Professor of Radiology and Surgery at the Hospital of the University of Pennsylvania, Philadelphia, PA. He has a special interest in chemoembolization and other loco-regional cancer therapies.
A variety of ablative techniques have been developed to complement the traditional surgical and oncologic approaches used in treating tumors. These techniques include transarterial chemoembolization, percutaneous ablation with chemicals such as alcohol or acetic acid, or percutaneous treatment with radiofrequency ablation or cryotherapy. The clinical management of primary and metastatic hepatic tumors can be especially challenging. Therefore, regional and local ablative techniques used in the treatment of hepatic tumors have been studied extensively. More recently, these techniques have been used in treating a variety of other tumors, including renal and osseous tumors.
Hepatocellular carcinoma (HCC) has a worldwide annual incidence of more than 1 million people, making it one of the most common fatal malignancies. Colorectal carcinoma is the third leading cause of death due to cancer in the United States and is frequently metastatic to the liver. Surgical excision is the ideal treatment for these tumors, but only 5% to 15% of patients are candidates, and the 5-year survival is 20% to 40%. 1-4 Systemic chemotherapy and external beam radiation therapy have limitations due to poor tumor response and hepatic toxicity. Regional and local ablative techniques continue to be refined in an attempt to achieve better outcomes for the large number of patients who are not operative candidates.
The intra-arterial administration of chemotherapeutic and embolic agents has many potential advantages, including increased concentration and dwell time of the chemotherapeutic agents within the liver, decreased systemic toxicity, the development of tumor ischemia, and ischemia-induced failure of cell membrane pumps leading to increased intracellular drug levels. 5
Patient selection --Candidates for chemoembolization must have their tumor confined to the liver, or the tumor must be liver-dominant and a significant source of morbidity and mortality. This generally includes patients with HCC and liver metastases from colorectal carcinoma, ocular melanoma, islet cell tumors, carcinoid tumor, and sarcomas. Occasionally, patients with liver metastases from other sites also are candidates. Assessment of portal venous flow is necessary, and if it is diminished the presence of collateral hepatopedal flow must be demonstrated. 6 Poor hepatopedal flow may necessitate more selective chemoembolization. Biliary obstruction increases the risk of biliary necrosis. Jaundice and hepatic encephalopathy are absolute contraindications. Patients with >50% liver volume replaced by tumor, lactate dehydrogenase (LDH) >425 IU/L, aspartate aminotransferase (AST) >100 IU/L, and total bilirubin >= 2 mg/dL are at increased risk for acute hepatic failure. 7
Procedure -- The procedure for chemoembolization at the University of Pennsylvania has been well described. 5 Three chemotherapeutic drugs are dissolved in contrast and emulsified with iodized oil. Polyvinyl alcohol (PVA) particles measuring 150 to 250 µm are added toward the end of the procedure. Embolization is performed until there is peripheral arterial pruning but not complete stasis of flow (figure 1). Standard orders for patients are listed in figure 2. Some institutions use different chemotherapeutic and embolic agents. Some institutions do not use iodized oil. The potential advantages of iodized oil include its drug-carrying ability, tumor-seeking ability, and embolic properties. 8 However, the dose of iodized oil should be <0.2 mg/kg to avoid liver and pulmonary toxicity. The final angiographic images help determine the need for repeat treatment, which usually is performed at 3- to 4-week intervals. Typically, 2 to 4 treatments are performed in a lobar or segmental distribution. Response is assessed using tumor markers and cross-sectional imaging. Distinguishing residual or recurrent disease from anatomic changes caused by the ablative procedure itself can be challenging. Murphy et al 9 proposed a window/level setting of 110/75 Hounsfield units to improve lesion detection on post-chemoembolization computed tomography (CT). Iman et al 10 used diffusion-weighted magnetic resonance imaging (MRI) to evaluate tumor necrosis post-chemoembolization and have found it especially useful with HCC. Fluoro-deoxyglucose-positron emission tomography (FDG-PET) has been found to be more accurate than CT in evaluating the efficacy of chemoembolization of HCC and colorectal metastases. 11
Complications -- Major complications occur in 3% to 4% of cases and include hepatic insufficiency or infarction, hepatic abscess, tumor rupture, surgical cholecystitis, and nontarget embolization. Geschwind et al 12 describe no significant deterioration in liver function following chemoembolization in 33 patients with Childs class A and 22 patients with Childs class B. The formation of liver abscesses has been associated with prior bilioenteric anastomosis despite standard antibiotic prophylaxis (figure 3). Liver abscesses occurred in 7 of 157 patients (8 of 397 procedures) with 6 of these patients having had a prior Whipple procedure. 13 Additional antibiotic prophylaxis and bowel preparation may be of benefit in this patient group.
Results --For HCC treated palliatively in a combined series of 800 patients from the United States, Europe, and Asia there was a 60% to 83% response rate characterized by decreasing serum alpha-fetoprotein and tumor volume. Probability of survival was 54% to 88%, 33% to 64%, and 18% to 51% at 1, 2, and 3 years, respectively. 14-20 A European multicenter trial of 100 patients (90% Stage I) showed survival rates of 62% and 38% at 1 and 2 years compared with survivals in nontreated patients of 43% and 26%. 21 A French multicenter trial showed similar results in more advanced disease (62% Stage II or III) with treated survival of 64% and 38% compared with nontreated survival of 18% and 6% at 1 and 2 years, respectively. 22 Prognostic factors include tumor size and type, staging, Childs class, and the degree of oil uptake by the tumor. 14-24 Uraki et al 23 reported a 23-month mean survival for patients with nodular-type HCC (11 patients) compared with a 10-month mean survival for patients with diffuse-type HCC (39 patients). Portal vein invasion was not found to be a significant prognostic factor. Balzano et al 25 have shown a 100% 12-month survival (43% at 2 years, 29% at 3 years) in 7 patients receiving chemoembolization (cisplatin and gelfoam) for recurrent HCC following liver transplantation. Patients received 4 to 12 cycles of chemoembolization repeated every 6 to 8 weeks.
Several Phase II studies have been performed for metastatic colorectal carcinoma demonstrating a 60% to 70% response rate and a 2-year median survival. 26-29 The American College of Radiology Imaging Network (ACRIN) is funding a randomized multicenter trial of systemic chemotherapy, with or without chemoembolization, to prospectively evaluate the survival benefit of chemoembolization for metastatic colon carcinoma.
With traditional therapy, median survival of metastatic ocular melanoma is 2 to 6 months. Median survival for 30 patients treated with chemoembolization for ocular melanoma (cisplatin and polyvinyl alcohol particles) at M.D. Anderson Cancer center was 11 months. 30 Mean survival for 28 patients treated with chemoembolization for ocular melanoma (BCNU [Carmustine, Bristol-Myers Squibb Oncology/Immunology Division, Princeton, NJ], Ethiodol [Savage Laboratories, Melville, NY], and gelatin sponge) at Thomas Jefferson University Hospital was 208 days (range 4 to 82 days). Tumor burden significantly influenced survival. Patients having <20%, 20% to 50%, and >50% liver replacement by tumor survived a mean of 471, 199, 107 days, respectively ( P = 0.0018). 31 Chemoembolization of hepatic metastases from breast carcinoma has been shown to decrease or stabilize the hepatic tumor burden in 7 of 8 patients treated at the University of Pennsylvania with the potential to palliate symptoms. However, mean survival following the first embolization is only 6 months due to development or progression of extrahepatic metastatic disease. 32
Results in neuroendocrine tumors-- Bland embolization of neuroendocrine tumors, especially carcinoid tumors, can lead to cessation of symptoms for 5 to 10 months in 90% to 100% of patients. Chemoembolization can increase the cessation of symptoms to nearly 2 years, but there is a concern for increased complications compared with bland embolization. 5,33-35 The release of vasoactive factors can lead to hypertensive crises as well as hypotension. Nowakowski et al 36 retrospectively evaluated 159 hepatic chemoembolization procedures in 80 patients with metastatic carcinoid tumor. Hypertensive or hypotensive events occurred in 4.4% of cases and were all controlled periprocedurally. Patients were premedicated with octreotide (100 to 500 mg every 8 hours), hydrocortisone (100 mg every 6 hours), and ondansetron. An anesthesiologist administered conscious sedation. There was 1 periprocedural death due to hepatorenal syndrome, but no deaths were reported due to the release of vasoactive factors. At the University of Pennsylvania, 24 patients were treated for hepatic metastases of neuroendocrine tumors with a major complication rate of 6.4% and 1 patient death due to liver failure. There was morphologic tumor regression in all 19 patients for whom follow-up imaging was available. Survival was roughly estimated in this small sample size as 71% and 58% at 1 and 2 years, respectively. 37
Newer therapies
The treatment of HCC with doxorubicin hydrochloride adsorbed to magnetic targeted carriers is being evaluated by Goodwin et al 38 at UCLA. An external magnet positioned over the tumor was activated during infusion of the agent into the hepatic artery. Patients were evaluated with MRI immediately following the procedure to assess the location of the magnetic targeted carriers. Tumor size was evaluated with CT at baseline and at 28 days. Targeting of the agent within the tumor was achieved in 19 of the 21 patients. No drug was detected in the systemic circulation. Preliminary data in 10 patients showed tumor progression in only 1 patient, stabilization in 5 patients, and minor or partial responses in 4 patients. Dosing of the agent based on size of the tumor is being investigated. Coldwell et al 39 are evaluating the treatment of primary and secondary hepatic tumors using intra-arterial embolization with Yttrium-90 glass microspheres. Patients received an average radiation dose of 146 Gray. Complications reported in 13 patients include 1 case of intrabdominal hemorrhage and 1 case of stroke 3 days following embolization. Additional outcomes have yet to be reported.
Ablation of hepatic malignancies using a direct percutaneous approach involves chemical and thermal techniques. Chemical ablation includes absolute alcohol or acetic acid injection, and thermal techniques consist of radiofrequency, cryo-, microwave, laser, or high-intensity ultrasound ablation. Chemical ablation causes coagulative necrosis due to cytoplasmic dehydration, denaturation of cellular proteins, and small vessel thrombosis. Thermal ablation creates a focal area of tissue coagulation dependent on the local temperature produced by the specific device.
Patient selection
Patients with unresectable, small, intrahepatic tumors that can be localized with ultrasound or CT imaging are the best candidates for direct percutaneous techniques. Patients with resectable tumors who are poor operative candidates may also be considered. Patients with tumors >3 cm in size or >3 in number have a poorer response to these techniques. 5
Percutaneous ethanol injection
Percutaneous ethanol injection (PEI) has been shown to be safe, effective, and inexpensive in treating small (<3 cm), unifocal hepatocellular carcinomas. 40,41
Procedure -- The procedure for PEI involves conscious sedation and can be done on an outpatient basis. Using sterile technique, following local anesthesia with Lidocaine, a 20-gauge needle (for example, a diamond tip, multi-sidehole Bernadino needle) is advanced under ultrasound or CT guidance to the far wall of the tumor and then slowly withdrawn as the ethanol is injected. Injection is discontinued if flow into adjacent structures is noted. Ethanol is brightly echogenic on ultrasound, likely due to microbubbles injected with the ethanol. Ethanol is hypodense on CT. The needle is left in place for 1 to 2 minutes and then withdrawn while aspirating. The total volume is calculated using the radius of the tumor and the formula for the volume of a sphere (4/3¼ [r+0.5] 3 ). The addition of 0.5 cm to the radius allows for a "tumor-free" margin. A 3-cm lesion therefore requires a total volume of 33 mL (Table 1). Lesions >4 cm usually require additional sessions due to alcohol toxicity (1 mL/kg). Follow-up evaluation is performed with CT, MRI, or PET and tumor markers.
Complications -- Pain and nausea during the procedure as well as fever and elevated liver enzymes in the subsequent few days are not uncommon. More significant complications occur in 1% to 4% of patients.
Results -- Complete necrosis occurs in 60% to 80% of patients, but 64% to 98% of patients develop new tumors in 5 years with a 5-year survival of 30% to 50%. 42 Patients with Childs class C have not demonstrated improved survival. 43 Use of ethanol following chemoembolization can improve ethanol diffusion. One study showed patients with tumors 3 to 8 cm in size having improved survival with ethanol following chemoembolization versus chemoembolization alone. 44 However, there are disadvantages to PEI. Multiple sessions are usually required, and treatment of multifocal disease is limited. PEI is less effective in treating metastatic disease, such as colorectal carcinoma, due to limited diffusion through this relatively firm tumor. 40,41,45 Because of these limitations, PEI is being replaced by other techniques in many centers.
Acetic acid ablation
Acetic acid has been shown by Ohnishi et al 46 to have superior cell kill at lower volumes compared with ethanol. Acetic acid has a higher degree of necrosis, more homogeneous diffusion, and is able to infiltrate tumor septae and capsules unlike ethanol.
Procedure -- Acetic acid is administered in a similar fashion to ethanol. Because of the increased diffusion, the dose is reduced by 1/3 compared with ethanol (Table 1) and the injection is performed very slowly. An injection >20 mL has the potential risk of renal toxicity and metabolic acidosis. As with alcohol, multiple sessions can be performed if necessary.
Results -- In a prospective randomized trial, Ohnishi et al 46 demonstrated a need for fewer treatment sessions and decreased volume with injections of acetic acid (31 patients) compared with ethanol (29 patients) for treatment of small, HCC (<3 cm). Cancer-free survival at 1 and 2 years was 83% and 63% with acetic acid, compared with 59% and 33% with ethanol. There were no major complications. Liang et al 47 treated 22 HCC nodules with a single acetic acid injection. Seventeen of 21 nodules evaluated on follow-up CT (at 6 to 29 months) showed complete necrosis. Injection was terminated prematurely in the other four nodules due to pain or intravasation of acetic acid. Three of these nodules showed complete necrosis following a second injection. Recently, acetic acid has been shown in vivo to produce significantly increased parenchymal diffusion and larger zones of necrosis in porcine liver. 48 The diffusion characteristics of acetic acid may make it a useful agent in treating metastatic disease to the liver.
Radiofrequency ablation
The use of radiofrequency ablation (RFA) for treating hepatic neoplasms has received much attention. The devices used in RFA produce alternating current in the radiofrequency range. This leads to ionic agitation and frictional heat extending into the tissues adjacent to the device with subsequent development of coagulative necrosis. Three radiofrequency devices are available in the United States (figure 4). The devices have received approval for treatment of surgically unresectable hepatic neoplasms by the Food and Drug Administration. Each system has differences in electrode and generator design. The RITA system (RITA Medical Systems, Mountain View, CA) uses 4 to 9 retractable needles housed in a 14- or 15-gauge outer needle. Temperature is monitored at the tips of the electrodes and wattage is adjusted up to a maximum of 150 W to maintain a target temperature for a set period of time. The ablation diameter is reported as 3 to 5 cm with the RITA Starburst XL. The RadioTherapeutics LeVeen Needle Electrode (RadioTherapeutics Corp., Sunnyvale, CA; distributed by Boston Scientific Corp., Burlington, MA) has 10 to 12 retractable needles housed in a 14- to 15-gauge outer needle with a deployed diameter of 2, 3.5, or 4 cm. A 200-W generator has recently been released. Instead of using tissue temperature, the device uses an ablation algorithm based on tissue impedance that increases with tissue desiccation. An anticipated maximum ablation diameter of 4 cm is reported by the manufacturer. The Radionics device (Tyco Healthcare, Burlington, MA) uses a hollow-tip 17-gauge needle as a single cooled or noncooled electrode or as a Cool-Tip cluster of three parallel electrodes. Cooling is performed using a saline pump and is thought to help reduce tissue impedance adjacent to the electrode tip. The power is supplied by a 200-W generator and is adjusted according to tissue impedance. Tissue temperature can be measured with a thermocouple at the electrode tip. A maximum ablation diameter of 4 to 5 cm is reported.
Procedure -- Radiofrequency ablation can be performed percutaneously, laparoscopically, or with laparotomy. Evaluation of the number of tumors and their size is important. Patients with fewer than 5 tumors <5 cm diameter, and with no extrahepatic tumors are good candidates. 49-52 Tumors numbering fewer than 2 and approaching 5 cm in size become difficult to fully ablate. 53 For a device producing approximately a 3-cm ablation, the largest tumor treated with a single ablation should be 2 cm, allowing for a tumor-free margin of 5 mm. Most devices produce approximately a 3-cm ablation, so the largest tumor treated with a single ablation should be 2 cm, allowing for a tumor-free margin of 5 mm. Larger tumors require overlapping ablations. One method involves creating overlapping spheres, which yields only 25% more ablation margin using two spheres in each plane (6 spheres total). Another method involves creating overlapping cylinders. 54 Each ablation can last 10 to 30 minutes. Careful preprocedural evaluation of the tumor is important to assess the best approach, identify the location of adjacent structures that may increase the complication risk, and determine the presence of vascular structures acting as potential heat sinks diminishing the thermal effect. Patients with Childs class C, active infection, or uncorrectable coagulopathy are not considered good candidates. Hepatocellular carcinoma and metastatic colon carcinoma are the most common neoplasms treated. Metastatic tumors from breast, pancreas, stomach, and neck as well as neuroendocrine tumors also have been treated. 53 The choice of approach is debated in the literature. A percutaneous approach with ultrasound or CT guidance can be performed on an outpatient basis with conscious sedation and with minimum morbidity (figure 5). Laparoscopy allows direct imaging of the liver with a high-frequency ultrasonic transducer. This improves detection and visualization of small tumors and affords more accurate staging. 53,55-57 In addition, a Pringle maneuver can be performed (occlusion of the hepatic artery and portal vein at the porta hepatis during treatment), which can increase the ablation margins. 52 However, laparoscopy is more invasive, and the approach is somewhat limited, depending on the sites chosen for the laparoscopic ports on the abdominal wall. Laparotomy has advantages similar to laparoscopy and improves access to the tumor, allowing possible resection or cryoablation, with the disadvantage of performing an open procedure. 58 The RITA and Radionics systems allow cauterization of the percutaneous tract. A shortened 6F or 7F sheath can be placed on the RadioTherapeutics electrode prior to insertion and later can be used for tract embolization using gelfoam pledgets (figure 5). The RadioTherapeutics system soon will have a coaxial needle electrode system with an introducer sheath (CoAccess, RadioTherapeutics Corporation, Sunnyvale, CA) to allow the introduction of a biopsy gun, gelfoam, or other device. 59 Follow-up evaluation usually is performed with CT (3-phase for HCC and 2-phase for colorectal metastases) and tumor markers. Newer imaging methods, as discussed with chemoembolization, may afford earlier detection of recurrence or new malignancy.
Complications -- Increased pain can occur with ablation of tumors near the liver capsule, gallbladder, main portal vessels, or diaphragm. Ablation of tumors near the gallbladder can cause cholecystitis. Ablation of tumors near the portal venous confluence increases the risk of biliary damage. Thermal necrosis in bowel loops adjacent to treated subcapsular lesions also can occur. Preventing thermal injury to the skin adjacent to the grounding pads requires appropriate placement of the pads on the thighs. 53,60,61 The overall complication rate is <5%.
Results -- Complete tumor necrosis rates of 50% to 95% have been reported. However, rates as low as 25% have been reported for tumors >5 cm in size. 53,62 The best local recurrence rate reported is 1.8% for primary and metastatic tumors following laparotomy and the use of a Pringle maneuver for 3 minutes. 52 Recurrence rates are higher with metastatic disease, most likely due to difficulty in detecting small lesions at the time of treatment. At the University of Pennsylvania, the cumulative risk of local recurrence is 15%, and the risk of new lesions is 64% at 1 year.
The use of modified Pringle maneuvers has been studied, including balloon occlusion of the hepatic artery or gelatin sponge embolization of hepatic arterial branches. For nodules with diameters 3.5 to 8.5 cm treated with RFA and a modified Pringle maneuver, Rossi et al 63 reported a local recurrence rate of 19%, and an overall intrahepatic recurrence rate of 45% at 1 year. These results may reflect preserved portal venous flow to the tumor, preventing formation of an adequate tumor-free margin. Curley et al 52 treated 169 hepatic tumors with RFA performed percutaneously (31 patients) or with laparotomy using a Pringle maneuver (92 patients). Median tumor size was 2.4 cm in the patients treated percutaneously and 3.8 cm in those patients treated surgically. Local recurrence was 1.8% at 15 months, and 72% of patients were free of tumor. Wood et al 64 treated 231 patients with unresectable hepatic tumors with RFA performed via percutaneous approach (25 patients), laparoscopy (27 patients), or laparotomy (39 patients). Intrahepatic ultrasound detected additional disease not evident with other imaging in 38% of cases. Resection and/or cryoablation were used in 38 of 84 patients. Median tumor size was 2 cm. The complication rate was 8%. Local recurrence was 18% at 9 months, and 43% of patients were free of tumor.
RFA has been shown to be more efficacious and to require fewer treatment sessions compared with PEI in treating HCC. Livraghi et al 62 demonstrated a higher rate of complete necrosis in small HCC treated with RFA (90%) versis PEI (80%). In addition, RFA required an average of 1.2 treatment sessions per tumor, compared with 4.8 sessions for PEI. RFA had a slightly higher complication rate, often related to tumor location and heating of adjacent organs. In these cases, the use of PEI may be more appropriate. As mentioned, PEI is not useful in treating metastatic disease. RFA has been shown to be cost-effective compared with palliative care in the treatment of HCC and metastatic colorectal carcinoma. 65 Radiofrequency ablation has been used as salvage therapy for refractory carcinoid metastases with promising results reported in 3 patients. 66
Cryosurgical ablation has higher morbidity than RFA but still is used to treat larger unresectable hepatic neoplasms. 58 In a prospective, nonrandomized trial, Pearson et al 67 demonstrated a 40.7% complication rate, including 1 postoperative death, with intraoperative cryoablation compared with a 3.3% complication rate and no deaths with intraoperative RFA. Tumor recurrence was 13.6% for cryoablation and 2.2% for RFA at 15 months.
Microwave coagulation therapy and laser photocoagulation are being used to treat hepatic malignancies in Europe and Japan. Shibata et al 68 recently reported that microwave coagulation therapy was as effective as surgery in the treatment of metastatic colorectal carcinoma. Thirty patients were randomized to microwave coagulation therapy or surgery. Mean survival for patients receiving microwave coagulation therapy during laparotomy was 27 months compared with a mean survival of 25 months for patients receiving hepatic resection. (Three-year survival rates were 14% and 23% for microwave versus surgery, P = nonsignificant.) The average tumor size was 2.7 cm. Complication rates were not significantly different, but patients receiving microwave coagulation therapy had decreased blood loss. Microwave coagulation therapy is most ideal in tumors <2 cm in size. It has been shown to be effective in HCC in a previous study. 69 Laser photocoagulation therapy has been described as effective, but much more interest centers on RFA in this country. 70
Accurately ablating the tumor and achieving adequate margins are crucial. Effective tumor detection also is important. Since hepatocellular carcinomas are supplied by the hepatic artery, a combined approach of hepatic arterial occlusion followed by radiofrequency ablation may prove to be beneficial. Occlusion of the hepatic artery can be performed with a modified Pringle maneuver using an occlusion balloon or gelfoam, or a course of chemoembolization can be administered prior to RFA. Using a Pringle maneuver during RFA performed during laparoscopy or laparotomy also has shown potential, as both the hepatic artery and portal vein can be occluded. As discussed, the latter methods also can have improved tumor detection in metastatic disease. Ultimately, combination therapy will have to be modified for each case based on tumor type, size, and number, as well as patient risk factors. A team approach to tumor management by oncologists, surgeons, and radiologists can provide the best care for these difficult cases.
Chemoembolization or RFA is also being used to treat malignancies elsewhere in the body.
Osseous tumors
RFA of both benign and malignant osseous tumors is being performed. Specifically, RFA is being used to treat osteoid osteomas. The conventional therapy for these benign, painful tumors is medical therapy with aspirin or nonsteroidal anti-inflammatory drugs or surgical or percutaneous resection. RFA of these tumors offers a less invasive approach and can be performed on an outpatient basis using CT guidance and general anesthesia or conscious sedation. Penetration of the cortex with a core bone biopsy needle and placement of the radiofrequency probe directly into the nidus are important. Both single and multi-electrode devices have been used. The procedure has been found to be safe and effective with pain relief reported in the literature in 83% to 91% of cases. 71-73 The use of RFA in primary and metastatic malignant tumors alone and in combination with radiation therapy is also being evaluated at many centers. There may be a role for RFA in local tumor control and management of pain.
Renal tumors
Intra-arterial embolization of renal angiomyolipomas for the prevention of hemorrhage is safe and effective. 74 Angiomyolipomas >= 4 cm are symptomatic in 82% to 94% of cases and hemorrhage spontaneously in 50% to 60% of cases. A variety of embolic agents have been used, including absolute alcohol, iodized oil, particles, and coils. The first two agents have the theoretical advantage of penetrating to the capillary level, causing effective tumor necrosis and avoiding repeat therapy due to the development of collaterals. The disadvantage of ethanol is the potential for reflux and non-target embolization and thrombosis. High quality, digital subtraction angiography performed prior to embolization is important in evaluating for the presence of aberrant anatomy and possible capsular collateral vessels communicating with lumbar and mesenteric vessels. An occlusion balloon can be used to prevent the reflux of ethanol. However, care must be taken, as aneurysm rupture has been reported as a complication with this technique. In smaller arteries, superselective catheters can be used to deliver the combination of ethanol with iodized oil in a 3:7 ratio (figure 6). Both methods have been performed at the University of Pennsylvania and have been found to be 90% effective in 5 patients over a mean follow-up period of 21 months. 75 Clinical symptoms disappeared in 13 of 14 patients treated by Han et al 74 over a mean follow-up period of 33 months. Han et al 74 also demonstrated a decrease in the angiomyogenic components of the tumors on follow-up CT. The treatment of renal cell carcinoma with radiofrequency ablation is being evaluated. This may prove to be useful in those patients who are not operative candidates or for the treatment of small, localized carcinomas. 76,77
Other tumors
Coldwell et al 78 are evaluating the use of intra-arterial platinol in the treatment of radioresistant head and neck squamous cell carcinomas. A dose of 75 mg/m 2 platinol was delivered every 2 weeks following superselective arterial catheterization. Follow-up CT was performed. Fourteen patients received an average of two infusions with complete response in 7 (50%), partial response in 3 (21%), stabilization in 2 (14%), and progression in 2 (14%). The treatment of desmoid tumors with percutaneous acetic acid injection is being performed at the University of Pennsylvania.
The role of the interventional radiologist in oncologic therapy is expanding. The treatment of hepatic tumors with regional and local ablative techniques continues to be refined, and similar techniques are being developed for the treatment of a variety of other tumors in the body. A combination of the available techniques most likely will offer the best therapy. The interventional radiologist has the opportunity to be an important member of the oncologic team, offering insight and assistance in the management of a variety of challenging cases. *


text:
Follow Us: Twitter | Facebook | Google+ | Pinterest | Quick Links: Join Blogger Programs | Join our partner Mommy's Club
I am not too impressed with what my facebook/twitter/rss buttons look like right now.
Could someone point me in the direction of where they got some unique or nice buttons for their site?
Thanks so much!
Tags: buttons, networking, social
I am brand new to blogging, can someone tell me how you even get these buttons on your site? I am also looking to add google friends, but I heard they are changing to google + and I am not sure how to go about that... I would love any ideas! Thanks!
I made mine too. If you know what you want maybe we could trade buttons for a banner posting?
© 2014 Created by Mom Bloggers Club.


text:
These projects have moved to https://code.google.com/p/jessies/. | ||||
software.jessies.org | Evergreen | salma-hayek | SCM | Terminator |
Terminator is a cross-platform GPL terminal emulator with advanced features not yet found elsewhere.
Terminator will run on any modern OS with Java 6 or later. It replaces xterm, rxvt, xwsh and friends on X11 systems, GNOME Terminal, KDE's Konsole, Apple's Terminal.app, and PuTTY on MS Windows.
[ ChangeLog | Download | FAQ | Report a Problem | Manual ]
Here are some of the features unique to Terminator, or which are rare amongst the competition:
Automatic Logging - Complete logs are automatically generated of all your terminal sessions [full details].
Drag & Drop - Text and URLs, and even files from Finder/Nautilus/Windows Explorer can be dropped on Terminator to be inserted as text, with automatic quoting of filenames containing shell meta-characters.
Find - Terminator provides you with a find function so you can search for text and regular expressions within your terminal (including the scrollback), highlighting them all, in the style of less(1), and offering quick movement to the next or previous match [full details]. As far as we know, the only other terminal emulator with a find function is Apple's Terminal, and ours is better.
Searches stay active until you cancel them, so if you're waiting for some particular output in a great stream of output, this is a really great way to make it blindingly obvious when it appears.
A screenshot of Terminator on Mac OS, after running 'man bash', and doing a find for '(?i)shell':
Despite the evidence that a pager is running, this is Terminator doing the highlighting — one of the authors uses cat(1) as his pager.
Freedom - Terminator is released under the GPL.
Horizontal Scrolling - Most terminal emulators wrap text when it intrudes upon the right margin. Terminator doesn't — it instead provides a horizontal scrollbar when necessary (hold down shift to make your scroll wheel scroll horizontally). This brings clear benefits in terms of readability of program output, or text files sent to the display with cat(1). (We tried both this and Apple-like reflowing of text when you change the window size, and we decided we preferred this. Sadly, we don't have the resources to support two implementations, so reflowing is no longer an option; it's gone from the code.)
Multiple Tabs - Like tabbed browsing, only with terminals [full details].
Number Reinterpretation - Terminator will recognize numbers in a variety of bases as the current selection, and add informational menu items to the pop-up menu showing the same number in other bases. No more man ascii or resorting to bc(1).
Open Terminator Here - Start a new terminal window in the directory you clicked on in Windows Explorer.
Portability - Written mostly in Java, with a small POSIX C++ part (for pseudo-terminal support) and a Ruby invocation script, Terminator should compile out of the box on most modern desktop operating systems. (Pre-built packages are available for most systems, so you don't need to worry about this.)
Now you can use the same great terminal emulator everywhere!
Proper Tab Character Handling - Most terminal emulators will translate tab characters into strings of spaces, which is very annoying if you then try to copy/paste a section of text from your terminal into a text editor. Terminator handles tabs properly, remembering where the tabs are and copy/pasting them as tab characters.
Unlimited Scrollback - Terminator won't throw away output when it scrolls off the top of the screen, nor when it reaches any arbitrary limit. You decide when, if ever, to clear the scrollback. (Even if you do clear the scrollback, you can still find lost text in the log, unless you turned that off too.)
Intelligent Vertical Scrolling - Terminator's scrollbar won't keep jumping when there's output if you've deliberately scrolled back to look at part of the history, but as soon as you scroll back to the bottom again, it will resume auto-scrolling. This gives you the best of both worlds without having to choose up-front via some configuration mechanism.
Fewer Gotchas - Terminator automatically turns off XON/XOFF flow control for terminal output. Being able to pause output by typing ^S and resume it by typing ^Q is much less useful given unlimited scrollback and intelligent vertical scrolling, and mainly leads to confusion when it's accidentally typed by someone who doesn't know about this functionality (or doesn't realize they've activated it). Turning off XON/XOFF allows Bash and Emacs, amongst others, to make use of these keystrokes.
A user who wants the XON/XOFF behavior – perhaps because they like to pause the output from commands like top(1) – can use stty ixon in their login script to re-enable it. Sadly, we can't just visibly indicate when ^S has stopped output, and provide help in re-starting output, because there's no way to read this aspect of tty state.
Safe Quit - Terminator knows when you still have processes running, and brings up a dialog rather than just letting those processes die.
UTF-8 - Terminator won't mangle your favorite accented characters, and it copes well with languages such as Greek where there's a mix of normal and wide glyphs:
The text is Markus Kuhn's UTF-8-demo.txt if you want to see what a mess Terminal.app makes of it. (On Mac OS, Terminal.app beats us on Thai, but we're better at Cyrillic, Greek, and Japanese. Results vary between platforms based on availability and suitability of fonts.)
One side-effect of proper support for variable-width glyphs is that you're not restricted to fixed-width fonts in Terminator, even if the only language you're using is English. GNU readline might get confused about the line length, though.
Here's a more convincingly terminal-like example of fixed-width English and variable-width Japanese; output from javac(1):
We think Terminator is the clear choice for the discerning terminal user. Though originally written for Linux to make up for the fact that no Linux terminal emulator was as good as Mac OS' Terminal, it has now surpassed Terminal in several areas.
Feel free to visit or join the terminator-users group.
Linux | ||
Linux x86 .deb for Debian/Ubuntu * | ||
Linux x64 .deb | ||
Linux x86 .rpm for Fedora/SUSE | ||
Linux x64 .rpm | ||
* Also available from our package repository. Using our Debian package repository. |
Mac OS | ||
Mac OS universal .zip (10.4 to 10.6) |
Windows | ||
Windows x86 .msi (Windows 2000 to Windows 7)* | ||
* Requires Cygwin <= 1.7.7 and Cygwin Ruby and 32 bit Java. Setting up Cygwin. Common Cygwin problems. |
If no pre-built package is available for your platform, or you just like building from source, anonymous read-only Subversion access is available. Copy and paste these commands to get everything you need:
mkdir ~/jessies && cd ~/jessies svn checkout http://software.jessies.org/svn/terminator/trunk/ terminator svn checkout http://software.jessies.org/svn/salma-hayek/trunk/ salma-hayek make -C salma-hayek && make -C terminator
You may want to add something like this to your crontab to keep up to date automatically (assuming your computer's on at 23:00):
00 23 * * * echo ~/jessies/salma-hayek/bin/nightly-build.rb | bash -l
There's also a source distribution, terminator-source.tar.gz, but Subversion makes it easier for you to keep up to date, and makes it easier to submit patches. (Note that you need to build salma-hayek before building any of our other projects.)
The hints for building are the same for all our projects.
If you just want to look, you can browse the repository.
The original implementation and documentation was written by Phil Norman.
The original idea of having a suitably hackable terminal emulator with which to experiment with advanced features came from Elliott Hughes, and he turned Phil's component into an application.
Martin Dorey was responsible for the Cygwin port; we wrote more about Porting JNI code to Win32 with Cygwin and java.io.FileDescriptor on Win32.
Phil wrote the code that took us from nothing to a more-or-less usable replacement for rxvt on his own between 2004-04-21 and 2004-05-28. Given that he was on holiday for a week during this time, that made roughly a month of development time.
Since then, Terminator has been on the long slog towards Joel's ten years of quality.
Sébastien Pierre contributed the icon.
Matt Hillsdon added URL highlighting and made Terminator easier to embed in Eclipse.
Costantino Cerbo added the close icons to tabs.
Ben Longbons rewrote the style attributes code, adding support for 256-color mode and konsole-compatible 24-bit color.
Simon Sadedin added support for block selection when dragging with the Ctrl key.


text:
氏写 @jackdglzn ?
active 5 months, 3 weeks ago
but now she seems very superdry uk but we look at them for what they can give us taken with harry
Provide attention to the proper way of driving your vehicle and applying excellent gasoline conservation practices, to ensure that whether you are driving on your own Edmonton Dodge or any kind of car design you are saving money.. If tanning […] View
Sorry, there was no activity found. Please try a different filter.


text:
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.com.
SOURCE Birlasoft
NEW DELHI, India, February 11, 2014 /PRNewswire/ --
Reassurance of Best Practices in Information Security at Birlasoft
Birlasoft, the global IT services arm of CK Birla group, has achieved yet another milestone in the journey of operational excellence by joining the International Organization for Standardization (ISO) 27001:2005 certified club of global organizations. The certification has been awarded to Global Development Centres and all business enabling support offices at Chennai, Hyderabad, Bangalore in India after a detailed audit conducted by BSI India Ltd, a part of British Standards Group.
(Logo: http://photos.prnewswire.com/prnh/20130923/642400 )
ISO/IEC 27001:2005 certified organizations adhere to global information security standards in providing core business services extended to clients along with operations supported by various internal functional/technical groups and departments. Securing the ISO/IEC 27001:2005 certification reconfirms Birlasoft as a secure, trustworthy and well managed business partner, providing assurance of information security management capabilities to its stakeholders.
In the times when information security and data protection are major concerns for global organization, this certification endorses Birlasoft's commitment to deliver secure services built to the highest global standards to its customers.
"It has been our constant endeavor to adopt industry best practices in the area of information security," said Preeti Das, CEO, Birlasoft. "The ISO/IEC 27001:2005 certification is an important milestone towards making Birlasoft a safe destination for solutions and services outsourcing. We are committed to deliver enhanced value through best-in-class information security processes to our customers. This is in sync with IT security consulting services offered to our clients."
About Birlasoft:
Birlasoft, part of 150 year old multi-billion dollar CK Birla Group, enables clients in Manufacturing, Banking & Financial Services, Insurance, Media & Healthcare industry, to become competitive in their business by providing value-based information technology services, in onshore, offshore and near-shore models. Birlasoft's portfolio of services includes Enterprise Application Services, Custom Application Services and Specialized services like Testing, Analytics and Mobility. Birlasoft's robust delivery processes embrace digitized project management methodologies, embedded within proven practices of Six Sigma, SEI CMMI Level 5 and a secure services framework. Birlasoft has presence across US, UK, Europe, APAC including India. For further information, visit http://www.birlasoft.com.
About ISO/IEC 27001:2005 Standard
ISO/IEC 27001 and its related code of practice, ISO/IEC 27002, provide internationally-accepted, standardized criteria for implementing an effective information security management system. The basis for this standard is that information is an organization's most valuable asset, and as such, information must be managed and protected from internal and external threats. ISO/IEC 27001 and ISO/IEC 27002 provide strategic and tactical direction for assessing, measuring, and preventing threats, and propose a range of security controls focused on safeguarding information assets.
For more information please contact:
Amit Tiwari
Manager - Global Marketing, Birlasoft
Email: email@example.com
©2012 PR Newswire. All Rights Reserved.


text:
« All Blogs
US Air Force girl gets tazed. Still easily gets the better end of this deal...
by BildoPoor guy...
Read More » -
Swedish Hunters Spend Night Terrified After Mistaking Cows for Bears
by Kelly MeyerThey weren't even drinking at the time. Here's the story
Read More » -
Awkward selfies at inappropriate places
by Laura BradshawSome people.... are enjoying the trend of taking selfies at certain places. Some of these places seem completely inappropriate. An...
Read More » -
Man Smashes His BMW
by Span -
Baby Vs Cat
by Mojo SideshowThis is just funny, I need to get this app for the tablet at home so I can have some fun with my son.
Read More » -
House Plumbed With Beer!
by Mojo SideshowHow about coming home to this practical joke. I wouldn't complain.
Read More » -
A Miraculous Celebration
by Joe CassadyA head-on collision occurred between a man and a woman. Both emerged from the scene intact while their cars were totally demolished...
Read More » -
Servers get a $200 tip!
by RatAt first when I saw this video I wasn't quite sure what was going to happen. The whole idea is what happens when you give a server a...
Read More »


text:
Sunday, March 09, 2014
Follow us:
Southern Tier
CORTLAND COUNTY, N.Y. -- A Cortland County man has been arrested and charged with rape. Police say John Phillips Jr., 24, of McGraw forced a woman to have sex with him while at a home in the Town of Cuyler last weekend. He is charged with first-degree rape, first-degree sexual abuse, sexual misconduct and forcible touching. Phillips was sent to the Cortland County Jail on $10,000 cash bail.